|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 2729173 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12758888.7 |
| Date of filing the European patent application | 2012-07-05 | |
| (97) | Date of publication of the European application | 2014-05-14 |
| (45) | Date of publication and mention of the grant of the patent | 2016-06-15 |
| (46) | Date of publication of the claims translation | 2016-10-10 |
| (86) | Number | PCT/IB2012/001619 |
| Date | 2012-07-05 |
| (87) | Number | WO 2013/005108 |
| Date | 2013-01-10 |
| (30) | Number | Date | Country code |
| 201161504737 P | 2011-07-06 | US |
| (72) |
KERSTEN, Christian, NO
CAMERON, Marte, Gronlie, NO
MJALAND, Svein, NO
|
| (73) |
Marte Grønlie CAMERON,
Major Laudalsvei 33, 4633 Kristiansand S,
NO
Christian KERSTEN, Maudsvei 98 , 4633 Kristiansand S, NO Svein MJALAND, Skippergata 104, 4633 Kristiansand S, NO |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | EGFR taikinių terapija |
| EGFR TARGETED THERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 14 | 289.00 EUR |
| 2026-07-05 |